COVID-19: An Update
European Respiratory Society (Verlag)
978-1-84984-181-8 (ISBN)
- Titel nicht im Sortiment
- Artikel merken
brings together a
truly international group of experts to consider areas such as: long-term sequelae in airway disease, in interstitial
lung disease, and in the immunocompromised; therapeutics in the community, hospital
and intensive care unit; and the pathophysiology and management of long COVID.
In May 2023, WHO declared that COVID-19
was no longer a public health emergency of international
concern. In 2024, COVID-19 certainly has not gone away, but
we can now take a more reflective look at the pandemic. This issue of the Monograph
does just that, bringing together a truly international group of experts, as befits a
global illness, to consider areas such as: long-term
sequelae in airway disease, interstitial lung disease, and in the
immunocompromised; therapeutics in the community, in hospital and in the
intensive care unit; and the pathophysiology and management of long COVID. The
Guest Editors also consider the impact of COVID-19 on clinical research and scientific
publishing, as well as looking to the future, considering what can be learnt
from the pandemic.
James D. Chalmers is Asthma and Lung UK Chair of Respiratory Research at the University of Dundee (Dundee, UK) and a Consultant Respiratory Physician at Ninewells Hospital (Dundee). Catia Cilloniz is Associate Professor at the School of Medicine of the University of Barcelona (Barcelona, Spain), Coordinator of the Pneumonia Research Group of Applied Research in Infectious Respiratory Disease and Critically Ill Patients Group of IDIBAPS at the Hospital Clinic of Barcelona (Barcelona), and Coordinator of the Worldwide Pneumonia Awareness Campaign: Pneumolight. Bin Cao is Director of the Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital (Beijing, China), and a professor at Peking Union Medical College, Capital Medical University, and Tsinghua University-Peking University Joint Center for Life Sciences (all Beijing).
The patient perspective of the pandemic
Timeline of the pandemic: epidemiology, global spread,
variants and waves
COVID-19 in adults: spectrum of illness and clinical
presentation
Cellular response in the pathogenesis of COVID-19
Antiviral therapy for COVID-19
Vaccination against COVID-19 in a post-pandemic era
Therapeutics in hospitalised adult patients with COVID-19
Management of severe COVID-19 in the ICU
Viral sepsis and SARS-CoV-2
Secondary infection after COVID-19
COVID-19 in the immunocompromised host
COVID-19 in patients with airways disease: COPD, asthma and
bronchiectasis
COVID-19 in patients with interstitial lung disease
Long COVID: epidemiology and clinical impact
Long COVID: pathological mechanisms
Long COVID: current management and future prospects
COVID-19 platform trials: insight and lessons in clinical
trial design
Publishing the pandemic: the impact of COVID-19 on science
and scientific publishing
Future perspectives: preventing the next pandemic
| Erscheinungsdatum | 03.09.2024 |
|---|---|
| Reihe/Serie | ERS Monograph ; 105 |
| Verlagsort | Sheffield |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Pneumologie |
| ISBN-10 | 1-84984-181-0 / 1849841810 |
| ISBN-13 | 978-1-84984-181-8 / 9781849841818 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
